☰

Rodica P. Bunaciu, Ph.D. - Publications

Affiliations: 
2005 University of Kentucky, Lexington, KY 
Area:
Toxicology, Nutrition, Oncology
Tree Info Grants Similar researchers PubMed Report error

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Dinh TA, Sritharan R, Smith FD, Francisco AB, Ma RK, Bunaciu RP, Kanke M, Danko CG, Massa AP, Scott JD, Sethupathy P. Hotspots of Aberrant Enhancer Activity in Fibrolamellar Carcinoma Reveal Candidate Oncogenic Pathways and Therapeutic Vulnerabilities. Cell Reports. 31: 107509. PMID 32294439 DOI: 10.1016/J.Celrep.2020.03.073  0.34
2018 Bunaciu RP, MacDonald RJ, Jensen HA, Gao F, Wang X, Johnson L, Varner JD, Yen A. Retinoic acid and 6-formylindolo(3,2-b)carbazole (FICZ) combination therapy reveals putative targets for enhancing response in non-APL AML. Leukemia & Lymphoma. 1-12. PMID 30570341 DOI: 10.1080/10428194.2018.1543880  0.347
2018 MacDonald RJ, Bunaciu RP, Ip V, Dai D, Tran D, Varner JD, Yen A. Src family kinase inhibitor bosutinib enhances retinoic acid-induced differentiation of HL-60 leukemia cells. Leukemia & Lymphoma. 1-11. PMID 29569971 DOI: 10.1080/10428194.2018.1452213  0.405
2018 Supnick HT, Bunaciu RP, Yen A. The c-Raf modulator RRD-251 enhances nuclear c-Raf/GSK-3/VDR axis signaling and augments 1,25-dihydroxyvitamin D3-induced differentiation of HL-60 myeloblastic leukemia cells. Oncotarget. 9: 9808-9824. PMID 29515772 DOI: 10.18632/Oncotarget.24275  0.399
2018 Bunaciu RP, MacDonald RJ, Gao F, Johnson LM, Varner JD, Wang X, Nataraj S, Guzman ML, Yen A. Potential for subsets of wt-NPM1 primary AML blasts to respond to retinoic acid treatment. Oncotarget. 9: 4134-4149. PMID 29423110 DOI: 10.18632/Oncotarget.23642  0.377
2017 Tasseff R, Jensen HA, Congleton J, Dai D, Rogers KV, Sagar A, Bunaciu RP, Yen A, Varner JD. An Effective Model of the Retinoic Acid Induced HL-60 Differentiation Program. Scientific Reports. 7: 14327. PMID 29085021 DOI: 10.1038/S41598-017-14523-5  0.338
2016 Wallace AS, Supnick HT, Bunaciu RP, Yen A. RRD-251 enhances All-trans retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells. Oncotarget. PMID 27331409 DOI: 10.18632/Oncotarget.10136  0.413
2015 Jensen HA, Yourish HB, Bunaciu RP, Varner JD, Yen A. Induced myelomonocytic differentiation in leukemia cells is accompanied by noncanonical transcription factor expression. Febs Open Bio. 5: 789-800. PMID 26566473 DOI: 10.1016/J.Fob.2015.09.008  0.413
2015 Bunaciu RP, Jensen HA, MacDonald RJ, LaTocha DH, Varner JD, Yen A. 6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells. Plos One. 10: e0135668. PMID 26287494 DOI: 10.1371/Journal.Pone.0135668  0.409
2015 Ibabao CN, Bunaciu RP, Schaefer DM, Yen A. The AhR agonist VAF347 augments retinoic acid-induced differentiation in leukemia cells. Febs Open Bio. 5: 308-18. PMID 25941627 DOI: 10.1016/J.Fob.2015.04.002  0.425
2015 Jensen HA, Bunaciu RP, Varner JD, Yen A. GW5074 and PP2 kinase inhibitors implicate nontraditional c-Raf and Lyn function as drivers of retinoic acid-induced maturation. Cellular Signalling. 27: 1666-75. PMID 25817574 DOI: 10.1016/J.Cellsig.2015.03.014  0.392
2015 Kim BJ, Zhao S, Bunaciu RP, Yen A, Wu M. A 3D in situ cell counter reveals that breast tumor cell (MDA-MB-231) proliferation rate is reduced by the collagen matrix density. Biotechnology Progress. PMID 25683564 DOI: 10.1002/Btpr.2062  0.312
2014 Jensen HA, Bunaciu RP, Ibabao CN, Myers R, Varner JD, Yen A. Retinoic acid therapy resistance progresses from unilineage to bilineage in HL-60 leukemic blasts. Plos One. 9: e98929. PMID 24922062 DOI: 10.1371/Journal.Pone.0098929  0.395
2013 Bunaciu RP, Yen A. 6-Formylindolo (3,2-b)carbazole (FICZ) enhances retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells. Molecular Cancer. 12: 39. PMID 23656719 DOI: 10.1186/1476-4598-12-39  0.41
2013 Jensen HA, Styskal LE, Tasseff R, Bunaciu RP, Congleton J, Varner JD, Yen A. The Src-family kinase inhibitor PP2 rescues inducible differentiation events in emergent retinoic acid-resistant myeloblastic leukemia cells. Plos One. 8: e58621. PMID 23554907 DOI: 10.1371/Journal.Pone.0058621  0.411
2011 Bunaciu RP, Tharappel JC, Lehmler HJ, Lee EY, Robertson LW, Bruckner GG, Spear BT, Glauert HP. Role of oil vehicle on hepatic cell proliferation in PCB-treated rats. Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society For Environmental Toxicology and Cancer. 30: 273-82. PMID 22181977 DOI: 10.1615/Jenvironpatholtoxicoloncol.V30.I4.10  0.57
2011 Shen M, Bunaciu RP, Congleton J, Jensen HA, Sayam LG, Varner JD, Yen A. Interferon regulatory factor-1 binds c-Cbl, enhances mitogen activated protein kinase signaling and promotes retinoic acid-induced differentiation of HL-60 human myelo-monoblastic leukemia cells. Leukemia & Lymphoma. 52: 2372-9. PMID 21740303 DOI: 10.3109/10428194.2011.603449  0.43
2011 Bunaciu RP, Yen A. Activation of the aryl hydrocarbon receptor AhR Promotes retinoic acid-induced differentiation of myeloblastic leukemia cells by restricting expression of the stem cell transcription factor Oct4. Cancer Research. 71: 2371-80. PMID 21262915 DOI: 10.1158/0008-5472.Can-10-2299  0.426
2010 Nayak S, Shen M, Bunaciu RP, Bloom SE, Varner JD, Yen A. Arsenic trioxide cooperates with all trans retinoic acid to enhance mitogen-activated protein kinase activation and differentiation in PML-RARalpha negative human myeloblastic leukemia cells. Leukemia & Lymphoma. 51: 1734-47. PMID 20615082 DOI: 10.3109/10428194.2010.501535  0.4
2009 Smith J, Bunaciu RP, Reiterer G, Coder D, George T, Asaly M, Yen A. Retinoic acid induces nuclear accumulation of Raf1 during differentiation of HL-60 cells. Experimental Cell Research. 315: 2241-8. PMID 19298812 DOI: 10.1016/J.Yexcr.2009.03.004  0.407
2008 Kauss MA, Reiterer G, Bunaciu RP, Yen A. Human myeloblastic leukemia cells (HL-60) express a membrane receptor for estrogen that signals and modulates retinoic acid-induced cell differentiation. Experimental Cell Research. 314: 2999-3006. PMID 18692045 DOI: 10.1016/J.Yexcr.2008.07.015  0.363
2008 Reiterer G, Bunaciu RP, Smith JL, Yen A. Inhibiting the platelet derived growth factor receptor increases signs of retinoic acid syndrome in myeloid differentiated HL-60 cells. Febs Letters. 582: 2508-14. PMID 18571505 DOI: 10.1016/J.Febslet.2008.06.016  0.397
2008 Bunaciu RP, Tang T, Mao CD. Differential expression of Wnt13 isoforms during leukemic cell differentiation. Oncology Reports. 20: 195-201. DOI: 10.3892/Or.20.1.195  0.329
2007 Bunaciu RP, Tharappel JC, Lehmler HJ, Kania-Korwel I, Robertson LW, Srinivasan C, Spear BT, Glauert HP. The effect of dietary glycine on the hepatic tumor promoting activity of polychlorinated biphenyls (PCBs) in rats. Toxicology. 239: 147-55. PMID 17703865 DOI: 10.1016/J.Tox.2007.06.102  0.616
2005 Glauert HP, Lu Z, Kumar A, Bunaciu RP, Patel S, Tharappel JC, Stemm DN, Lehmler HJ, Lee EY, Robertson LW, Spear BT. Dietary vitamin E does not inhibit the promotion of liver carcinogenesis by polychlorinated biphenyls in rats. The Journal of Nutrition. 135: 283-6. PMID 15671227 DOI: 10.1093/Jn/135.2.283  0.586
Show low-probability matches.